جستجوی استاد راهنمای دانشگاهی

برای مسیر پژوهشی‌تان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آن‌ها ارتباط بگیرید.

نمایش ۷۳۶-۷۵۰ از ۱٬۵۴۰ استاد راهنما

اطلاعات پروفایل‌ها از صفحات عمومی دانشگاه‌ها گرفته شده و ممکن است به‌روز نباشد.

Weidong Caiمشاهده پروفایل

دانشیار

University of SydneyAustralia

Associate Professor Weidong Cai is affiliated with the University of Sydney's School of Computer Science, serving as Director of the Multimedia Lab and Associate Director of the Biomedical & Multimedia Information Technology (BMIT) Research Group. He has held visiting roles at Harvard Medical School and holds a PhD in Computer Science from the University of Sydney. His research focuses on medical image computing, computer vision, machine learning, and computational neuroscience, with over 300 peer-reviewed publications. Dr. Cai leads projects on 3D point cloud processing, label-efficient learning, cross-domain medical image analysis, and neuroimaging computing. Dr. Cai's educational background includes a PhD from the University of Sydney (2001) and postdoctoral experience at Harvard Medical School (2014). He supervises students in courses like COMP3419 Graphics and Multimedia and COMP5424 Information Technology in Biomedicine. His current research explores cutting-edge topics like 3D neuron reconstruction, multimodal neuroimaging, and AI-driven medical diagnostics. His research interests span medical imaging, bioinformatics, and computer vision, with a focus on developing algorithms for big data analytics, deep learning, and biomedical applications. Projects include automated neuron tracing, cross-domain adaptation for medical imaging, and geometric deep learning for neuroimaging analysis. Dr. Cai's students have received numerous awards, including the MICCAI IUGC Grand Challenge (2024) and IEEE ISBI Travel Grants. He serves on editorial boards for journals like IEEE Transactions on Image Processing and Brain Informatics, and co-edits Springer's Brain Informatics & Health book series. His lab, the Multimedia Lab, collaborates on projects like 3D point cloud applications, label-efficient feature learning, and cross-domain medical image analysis. Research teams include the BMIT group, focusing on biomedical and multimedia technologies.

پروفایل رسمی دانشگاه

Erika Lynn Nurmiمشاهده پروفایل

دانشیار

University of California, Los AngelesUnited States

Erika Lynn Nurmi serves as an Associate Professor-in-Residence within the Department of Psychiatry and Biobehavioral Sciences at the University of California Los Angeles (UCLA) School of Medicine. Her academic career bridges clinical psychiatry with cutting-edge research in psychiatric genetics and neuroimaging. Dr. Nurmi's research program focuses on obsessive-compulsive disorder (OCD), where she has made significant contributions through her leadership in the ENIGMA-OCD consortium, an international collaboration analyzing neuroimaging data across multiple sites worldwide. Her work spans genetic investigations of OCD susceptibility, neuroanatomical correlates of the disorder, and predictive modeling of treatment response to cognitive behavioral therapy. She has also pioneered research examining the relationship between the gut microbiome and psychiatric symptoms, particularly regarding antipsychotic-induced weight gain mechanisms. Analysis of her recent publications reveals a sophisticated multi-modal approach to psychiatric research, integrating genetics, neuroimaging, and clinical data. Her 2025 Nature Genetics paper identifying 30 loci associated with OCD represents a landmark contribution to the field, while her machine learning models for predicting CBT response demonstrate translational applications of her work. The recurring theme across her publications is the search for biological markers that can inform more personalized treatment approaches for psychiatric disorders. Principal Investigator on NIH R21HD095548: 'The role of bile acid-microbiome cross-talk in psychotropic-induced weight gain and cardiometabolic dysfunction' (2019-2021) Principal Investigator on NIH R03MH112032: 'Genetic basis of inhibitory cognitive control as a dimensional construct spanning psychiatric illness' (2017-2020) Principal Investigator on NIH K23MH094613: 'Next generation risk variant discovery in a highly penetrant OCD subtype' (2011-2016) Her research is conducted through extensive collaborations with the ENIGMA-OCD working group and other international consortia, allowing for large-scale analyses that have identified consistent patterns of brain structure abnormalities and genetic variants associated with OCD across the lifespan. Dr. Nurmi's integrative approach bridges basic science discoveries with clinical applications, aiming to develop more personalized and effective treatments for psychiatric disorders.

پروفایل رسمی دانشگاه

BENEDETTI FRANCESCOمشاهده پروفایل

استاد

Vita-Salute San Raffaele UniversityItaly

Francesco Benedetti is a Second-level Professor of Psychiatry at Vita-Salute San Raffaele University in Milan, affiliated with the Faculty of Medicine and Surgery. He leads the Clinical Research Group in Psychiatry and Clinical Neurosciences at IRCCS San Raffaele Hospital. His academic roles include heading the Psychiatry and Clinical Psychobiology Research Unit and serving as director of the Department of Clinical Neurosciences. He holds qualifications in Psychiatry, Clinical Psychology, and is a National Scientific Qualifier for full professorship in Psychiatry (06/D5). Education includes a Medical Degree from University of Modena (1991), specializations in Clinical Psychology (1995, University of Milan) and Psychiatry (2005, Vita-Salute San Raffaele). His research focuses on psychiatric neurosciences, neuroimaging, mood disorders, chronobiology, and neuroinflammation, with contributions to international networks like ENIGMA and MOODSTRATIFICATION. Research interests emphasize brain structure-function relationships, treatment-resistant depression, and biomarkers for mood disorders. He has published ~583 articles, including work on AI-driven brain anomaly detection, longitudinal suicide risk prediction, and neuroimmune mechanisms in depression. Awards: ISBD Best Poster (2008), ECNP Best Poster (2001), Antonio D'Errico Prize (2000) Editorial Roles: Associate Editor for Frontiers in Physiology, Editor for Neurology Psychiatry & Brain Research Grants/Networks: EU-funded MOODSTRATIFICATION (2018–present), ENIGMA Neuroimaging Genetics (2017–present) Teaching: Leads Psychiatry modules (1170-11/12) for Medicine students He is a Fellow of major psychiatric societies (WFSBP, CINP, SLTBR) and chairs European Psychopathology Summer Schools. His work bridges clinical psychiatry with advanced neurobiological research, addressing translational challenges in mental health.

پروفایل رسمی دانشگاه

Marcella Bellaniمشاهده پروفایل

دانشیار

Verona UniversityItaly

Marcella Bellani is an Associate Professor at the University of Verona's Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry and Clinical Psychology. She chairs the Neuroimaging Section of the European Psychiatric Association and directs the Brain Imaging and Neuropsychology Research Unit. Her research focuses on applying neuroimaging techniques (MRI, fMRI) to study psychiatric disorders, with emphasis on biomarkers for early diagnosis and intervention. She investigates psychiatric disorders like bipolar disorder, schizophrenia, and depression using translational approaches combining neuroimaging, neuropsychology, and rehabilitation strategies. Her teaching roles include contributing to medical and psychiatric rehabilitation programs, covering topics like psychiatry fundamentals and cognitive therapy principles. She actively participates in postgraduate psychiatry specialization courses, overseeing clinical case discussions and literature updates. Bellani's work integrates computational neuroscience methods to analyze brain structure/function relationships, with recent projects exploring machine learning applications in mental health diagnostics. Her research unit collaborates internationally through initiatives like the ECNP neuroimaging network, emphasizing data harmonization for large-scale studies. Key areas include the impact of inflammation on brain microstructure in psychosis, cognitive remediation therapies, and digital interventions for social isolation. She advocates for ethical considerations in psychiatric care, such as opposing assisted suicide for severe depression cases.

پروفایل رسمی دانشگاه

Jianli Sunمشاهده پروفایل

دانشیار

Delaware State UniversityUnited States

Jianli Sun, Ph.D., is an Associate Professor at Delaware State University (DSU) within the Department of Biological Sciences. His research focuses on understanding neural defects in the cerebellum of spinal muscular atrophy (SMA) mouse models, employing techniques such as electrophysiology, immunohistochemistry, MRI, and single-cell RNA sequencing. He leads a lab recognized for pioneering studies on cerebellar pathology in SMA, including the 2023 discovery of structural and functional defects in Purkinje cells. His work is supported by an R15 grant from the National Institute of Neurological Disorders and Stroke (NINDS) awarded in 2022. Education: B.S. in Biology M.S. in Physiology Ph.D. in Neurobiology & Neuroscience from Fudan University (2005) Research Interests: Dr. Sun’s work bridges neurobiology and clinical research, emphasizing SMA’s multisystem impact. His studies investigate mechanisms of cerebellar degeneration, sex-based vulnerabilities in SMA patients, and the role of the SMN protein. Recent findings highlight the cerebellum’s critical role in SMA, challenging prior views of it as solely a lower motor neuron disease. Scientific Contributions: His articles (2021–2025) explore cerebellar dysfunction, cortical circuitry evolution, and neurotrauma’s impact on axonal function. Key themes include translational research linking animal models to human pathology, with a focus on neuroimaging and genetic techniques. Grants & Funding: A 2022 NINDS R15 grant enabled his SMA cerebellar pathology research. This funding supports ongoing investigations into Purkinje cell degeneration mechanisms. Labs/Teams: His lab collaborates on multisystem SMA research, integrating cutting-edge methods to advance understanding of neurodegenerative mechanisms.

پروفایل رسمی دانشگاه

Chris Risherمشاهده پروفایل

دانشیار

Marshall UniversityUnited States

Chris Risher is an Associate Professor in the Department of Biomedical Sciences at Marshall University. His research investigates astrocyte-mediated regulation of synaptic development and its implications for neurodevelopmental disorders. The lab employs transgenic mouse models, in vitro systems, and high-resolution 3D reconstructions to study synaptic maturation. Research focuses on identifying molecular pathways linking astrocytes to synaptic structures disrupted in autism, schizophrenia, and addiction. Recent publications (2021-2025) examine synaptic quantification methods, astrocyte morphology changes following opioid exposure, and mesolimbic pathway alterations. Laboratory personnel include PhD candidates and undergraduate researchers. Current projects investigate thrombospondin signaling, dendritic spine analysis, and developing novel therapeutic strategies for synaptic disorders.

پروفایل رسمی دانشگاه

Andreana Miquela Benitezمشاهده پروفایل

دانشیار

Medical University of South CarolinaUnited States

Andreana Miquela Benitez, PhD, is an Associate Professor in the Department of Neurology at the Medical University of South Carolina's College of Medicine. Her research focuses on brain aging mechanisms, Alzheimer's disease, and vascular cognitive impairment. She leads studies using advanced neuroimaging techniques like diffusion MRI and functional connectivity analysis to understand cognitive decline pathways. Current projects include: Quantitative neuroimaging of white matter integrity in aging and Alzheimer's Non-invasive brain stimulation trials for mild cognitive impairment Investigating cannabis use impacts on older adults' cognition and stress reactivity Geospatial analysis of Alzheimer's prevalence linked to healthcare policies Her lab develops novel imaging analysis tools like PyDesigner for diffusion MRI processing. Dr. Benitez collaborates across disciplines to address neurodegenerative disease mechanisms and interventions. She has pioneered studies linking oral microbiome changes to neurological disorders through cannabis use.

پروفایل رسمی دانشگاه

Lifang Heمشاهده پروفایل

دانشیار

Lehigh UniversityUnited States

Lifang He is an Associate Professor in the Department of Computer Science & Engineering at Lehigh University. She holds a B.S. in Computational Mathematics from Northwest Normal University and a Ph.D. in Computer Science from South China University of Technology. Prior to joining Lehigh, she was a postdoctoral researcher at the University of Pennsylvania’s Perelman School of Medicine and Weill Cornell Medical College. Her research focuses on machine learning/deep learning, data mining, tensor analysis, and biomedical informatics. Notable projects include developing BiomedGPT, an AI model for real-time patient-focused insights, and contributions to structural brain imaging analysis and rare event prediction in materials science. Her work bridges computational methods with healthcare applications, emphasizing multi-modal data fusion and federated learning in medical contexts. Recent publications span topics like self-paced learning for sign language recognition, graph-based brain network analysis, and efficient large language models. She actively participates in symposiums on AI in healthcare and has collaborated on initiatives like the Mountaintop Campus’ interdisciplinary projects.

پروفایل رسمی دانشگاه

Diana M. Robinsonمشاهده پروفایل

استادیار

University of Texas Southwestern Medical CenterUnited States

Dr. Diana M. Robinson is an Assistant Professor in the Department of Psychiatry at the University of Texas Southwestern Medical Center. She serves as the Associate Medical Director of the Parkland Health Consultation and Liaison Psychiatry Service and participates in the Texas Child Mental Health Care Consortium's Perinatal Psychiatry Access Network (PeriPAN), a statewide initiative supporting perinatal mental health care. Dr. Robinson received her medical degree from Texas A&M College of Medicine, completed psychiatry residency at the University of Virginia, and fellowship training in Consultation-Liaison Psychiatry at Harvard's Brigham & Women's Hospital, specializing in cardiac transplantation psychiatry, oncology, and infectious disease psychiatry. Her research focuses on neuropsychiatry, psychiatry trainee education, and women's mental health, with particular emphasis on the psychiatric aspects of medical conditions. Dr. Robinson maintains active professional engagement through the Academy of Consultation-Liaison Psychiatry (Annual Meeting Committee member since 2017), American Psychiatric Association, and Society for the Study of Psychiatry and Culture. Analysis of her 15 most recent publications reveals strong research concentrations in neuropsychiatric sequelae of medical conditions (especially COVID-19), psychopharmacology, medical education, and healthcare equity. Her work frequently examines complex cases at the psychiatry-medicine interface and develops practical clinical strategies for challenging scenarios. Dr. Robinson leads multidisciplinary clinical teams at Parkland Health and contributes to systemic mental health improvements through statewide perinatal psychiatry initiatives. Her work demonstrates consistent commitment to advancing consultation-liaison psychiatry through education, clinical innovation, and health system reform.

پروفایل رسمی دانشگاه

Tomoki Arichiمشاهده پروفایل

استاد بالینی

King’s College LondonUnited Kingdom

Dr. Tomoki Arichi is a Clinical Professor of Perinatal Neuroscience at King's College London and Head of the Research Department of Early Life Imaging. He holds an honorary position as a Consultant in Paediatric Neurodisability at the Evelina London Children's Hospital. His work focuses on using advanced neuroimaging techniques (e.g., fMRI, EEG) to study neonatal brain development and injury. He leads collaborations with institutions like Imperial College London's Human Robotics Group to develop rehabilitative tools for infants with brain injuries. Education: PhD in functional MRI from Imperial College London (2012), MRC Clinician Scientist (2017), and MRC Senior Clinical Fellow (2024). Key awards include the BPNA Ronnie MacKeith Prize (2014) and King's Engaged Research Award (2025). Research interests span neonatal brain imaging, functional connectivity, and robotics-assisted therapies. His group's work contributes to Sustainable Development Goals related to health and education.

پروفایل رسمی دانشگاه

Maria-Elena Torres-Padillaمشاهده پروفایل

استاد

Helmholtz Centre MunichGermany

Prof. Maria-Elena Torres-Padilla is a prominent academic leading research in epigenetics and stem cell biology. She holds the position of Professor for Stem Cell Biology at Ludwig-Maximilians-University Munich (LMU) and is Director of multiple institutes, including the Institute for Epigenetics and Stem Cells and the Stem Cell Center at Helmholtz Munich. Her work focuses on understanding the epigenetic mechanisms underlying cellular reprogramming, totipotency, and early embryonic development. Education: Maria-Elena earned her undergraduate degree in Biology from the National University of Mexico (UNAM), followed by a PhD in Molecular Biology at the Institut Pasteur in Paris. She completed her postdoctoral training at the Gurdon Institute, University of Cambridge, before establishing her independent research group in 2008. Research Interests: Her lab investigates how chromatin dynamics and epigenetic regulation shape cell fate decisions in early embryos. Key areas include the role of histone modifications, nuclear organization, and transposable elements in maintaining totipotency and driving cellular plasticity. Her work aims to engineer cells for regenerative therapies targeting neurodegenerative diseases and brain injuries. Publications: Recent work highlights discoveries in nuclear architecture, epigenetic pathways, and transposable element regulation during embryogenesis. These studies underscore the importance of chromatin dynamics in developmental processes and therapeutic applications. Awards: She has received prestigious accolades, including the 2025 Leibniz Prize (Germany’s highest scientific honor), membership in the German Academy of Sciences Leopoldina, and recognition by the World Economic Forum as a Young Scientist. Advising & Grants: She mentors a multidisciplinary team of postdocs and doctoral researchers, fostering a diverse and collaborative environment. Her lab’s funding includes ERC grants and initiatives like the LifeTime European Initiative, supporting her vision to bridge basic and translational research. Labs & Teams: The Torres-Padilla Lab at Helmholtz Munich integrates microscopy, genomics, and computational biology to study epigenetic principles in development. Collaborations span disciplines, including the Epigenetics@HelmholtzMunich network, to advance cell-based therapies. Her future work aims to leverage epigenetic insights to create ‘cells à la carte’ for regenerative medicine, emphasizing ethical and societal impacts of scientific innovation.

پروفایل رسمی دانشگاه

Paul Thompsonمشاهده پروفایل

استاد بالینی

University of MontrealCanada

Paul Thompson is a Clinical Professor at the Université de Montréal's Faculty of Medicine, Department of Ophthalmology. He practices at the Centre hospitalier de l'Université de Montréal (CHUM) and holds research affiliations with the CRCHUM. His expertise spans corneal diseases, clinical ophthalmology, and interdisciplinary epilepsy research through collaborations like the ENIGMA consortium. Education: MD and Ophthalmology specialization from Université de Montréal, with fellowships in corneal disease at Hôtel-Dieu de Paris and Harvard Medical School's Massachusetts Eye and Ear Infirmary. Research focuses on corneal pathology, including keratoprosthesis innovations, and neuroimaging studies of epilepsy's structural brain changes. Collaborative projects include AI-driven epilepsy classification and genetic influences on brain structure. Labs/Teams: Leads the corneal fellowship program at CHUM and participates in the ENIGMA-Epilepsy Working Group. Research interests bridge ophthalmology and neurology, with emphasis on clinical translation and imaging biomarkers.

پروفایل رسمی دانشگاه

Christopher David Vigerمشاهده پروفایل

دانشیار

Western UniversityCanada

Christopher David Viger is an Associate Professor in the Department of Philosophy at Western University, holding a dual affiliation with the Rotman Institute of Philosophy. Based in the Western Interdisciplinary Research Building in London, Ontario, he serves as Assistant Department Chair and contributes to the Philosophy of Mind and Cognitive Science research domain within the Rotman Institute. His educational background includes foundational training in mathematics and logic, followed by retraining in philosophy at Carleton University under Andrew Brook. He completed his PhD in Philosophy at McGill University supervised by Paul Pietroski, after which he held postdoctoral positions at Tufts University (with Daniel Dennett), Dalhousie University, and the CUNY Graduate Center/Rutgers Center for Cognitive Science. Dr. Viger's research centers on the language-thought relationship , where he developed the Acquired Language of Thought Hypothesis (ALOT) challenging traditional LOT models. He argues conceptual structure interfaces specialized processing modules, with compositionality emerging from natural language rather than innate cognition. His newer work investigates neural connectivity to explain implicit bias, dual process theory failures, and limitations in brain training applications, aiming to improve critical thinking pedagogy. His publication trajectory shows consistent focus on foundational cognitive questions, with recent work (2018-2024) examining language ontology and interpretive effects, while maintaining engagement with core themes like conceptual compositionality and the binding problem. Early influential contributions addressed LOT critiques and philosophical logic puzzles. Key recognitions include: Marilyn Robinson Teaching Award (2008) SSHRC Postdoctoral Fellowship Rotman Faculty Fellowship in Philosophy and Neuroscience (2012-2014) Administratively, he served as Undergraduate Chair (2010-2014) while maintaining active research collaborations across institutions. His work bridges philosophy, cognitive science, and neuroscience through the Rotman Institute's interdisciplinary framework, with recent scholarship increasingly addressing educational applications of cognitive theory. Dr. Viger maintains strong institutional presence through the Rotman Institute's Philosophy of Mind and Cognitive Science domain, collaborating with researchers like Tim Bayne and Mel Goodale. His postdoctoral work with Daniel Dennett at Tufts established enduring connections to major cognitive science centers, reflected in ongoing engagement with CUNY and Rutgers research networks.

پروفایل رسمی دانشگاه

Marek Napieralaمشاهده پروفایل

استاد

University of Texas Southwestern Medical CenterUnited States

Marek Napierala, Ph.D. is a Professor in the Department of Neurology at The University of Texas Southwestern Medical Center, part of the Peter O'Donnell Jr. Brain Institute. He joined UT Southwestern in 2022 after serving as an Associate Professor at the University of Alabama at Birmingham. His research focuses on molecular mechanisms underlying Friedreich's Ataxia (FRDA), a neurodegenerative disorder caused by expanded GAA repeat sequences in the FXN gene. Dr. Napierala's work integrates cellular and mouse models, induced pluripotent stem cells (iPSCs), and genome editing to study FRDA pathogenesis and therapeutic strategies. Education: M.S. in Biotechnology, Adam Mickiewicz University, Poland (1990s) Ph.D. in Biochemistry, Institute of Bioorganic Chemistry, Polish Academy of Sciences (1999) Research Interests: Mechanisms of GAA repeat expansion and transcriptional silencing in FRDA Development of gene therapy and antisense oligonucleotide approaches CRISPR-based genome editing for FRDA correction Identification of biomarkers and disease progression indicators Key Contributions: Established the Friedreich’s Ataxia Cell Line Repository, the world's largest fibroblast and iPSC bank from FRDA patients. Advocacy and collaboration with FRDA patient communities, including annual patient meetings and participation in rideATAXIA events. Member of the Scientific Advisory Board of the Friedreich’s Ataxia Research Alliance (FARA). Labs & Teams: The Napierala Lab focuses on multidisciplinary approaches to FRDA, including iPSC differentiation into neurons and cardiomyocytes, CRISPR-based editing, and translational drug discovery. Collaborations include the Peter O'Donnell Jr. Brain Institute and global FRDA research networks.

پروفایل رسمی دانشگاه

Michele Scandolaمشاهده پروفایل

دانشیار

Verona UniversityItaly

Michele Scandola is an Associate Professor at the University of Verona's Department of Human Sciences. He specializes in neuropsychology, cognitive neuroscience, and the application of virtual reality (VR) in clinical and research settings. His work focuses on body representation, peripersonal space perception, and the impact of spinal cord injuries on cognition and emotion. Scandola holds a PhD from Sapienza University of Rome (cum laude) and has collaborated with European research groups on projects involving VR, neurorehabilitation, and Bayesian statistical methods. Education: PhD in Psychology from Sapienza University of Rome (2014, cum laude) Research Interests: Embodied cognition, chronic pain and body perception, VR-based interventions, and neuropsychological assessment Roles: Member of the Departmental Council, FUR Committee, and Scientific Committee of the PhD program in Human Sciences His research combines experimental methods with clinical applications, exploring how sensory-motor deficits influence higher-order cognitive functions. He has published extensively on topics like spinal cord injury-induced cognitive changes, pain perception, and the use of Bayesian statistics in cognitive sciences. Scandola teaches courses on psychobiology, neurosciences in education, and systematic review methodologies. He leads the NPSY-Lab.VR (Laboratory of Neuropsychology) and collaborates with the CognitiveMetrix spin-off on VR and neurotechnology projects.

پروفایل رسمی دانشگاه